Fennec Pharmaceuticals Inc. (FENC) — Stock Score Summary

Fennec Pharmaceuticals Inc. (FENC) has a MoatMap StockRank of 64/100 based on Quality (44/100), Value (38/100), and Momentum (66/100) factor scores. The current signal is HOLD. Fennec Pharmaceuticals is a single-product specialty pharma company. It does not possess the diversified, high-utilization CDMO manufacturing moat required to play our CDMO theme, making it too speculative for our concentrated book.

Fennec Pharmaceuticals is a specialty pharmaceutical company focused on oncology supportive care. Its lead product, PEDMARK (sodium thiosulfate), is the first and only FDA-approved therapy to reduce the risk of ototoxicity associated with cisplatin chemotherapy in pediatric patients with localized, non-metastatic solid tumors. The company occupies a critical niche addressing an unmet medical need in pediatric cancer care.

Key Financial Metrics

Price$8.77
Market Cap$344M
P/E (Forward)8.92
Price/Book8.40
Return on Equity-52.7%
Return on Invested Capital-12.6%
Gross Margin92.2%
Operating Margin-0.8%
Revenue Growth72.6%
Free Cash Flow$-2M

Fennec Pharmaceuticals Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Fennec Pharmaceuticals Inc.’s (FENC) StockRank?
MoatMap’s StockRank for Fennec Pharmaceuticals Inc. (FENC) is 64/100, with a Hold signal. It is a composite of Quality (44), Value (38), and Momentum (66) factor ranks across MoatMap’s 19,000+ stock universe.
Does Fennec Pharmaceuticals Inc. have an economic moat?
Fennec Pharmaceuticals Inc. (FENC) has a Quality factor score of 44/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Fennec Pharmaceuticals Inc. a buy, hold, or sell?
MoatMap’s current signal for Fennec Pharmaceuticals Inc. (FENC) is Hold, based on a StockRank of 64/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Fennec Pharmaceuticals Inc. in?
Fennec Pharmaceuticals Inc. (FENC) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksFENC deep dive reportAI ChampionsHow we score stocksSense-check another stock